12 Health Care Stocks Moving In Tuesday's Intraday Session
Portfolio Pulse from Benzinga Insights
During Tuesday's intraday session, several healthcare stocks experienced significant movements. Nkarta, Assembly Biosciences, Olink Holding, Anebulo Pharmaceuticals, Moleculin Biotech, and OpGen saw their shares rise, while Evelo Biosciences, Monte Rosa Therapeutics, Celcuity, Tiziana Life Sciences, Better Therapeutics, and Nuvectis Pharma experienced a decline in their stock prices.
October 17, 2023 | 5:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Anebulo Pharmaceuticals' stock moved upwards by 42.69% to $2.44.
The significant increase in Anebulo Pharmaceuticals' share price is likely to have a positive impact on its stock in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Assembly Biosciences' shares moved upwards by 82.98% to $1.33.
The significant increase in Assembly Biosciences' share price is likely to have a positive impact on its stock in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Moleculin Biotech's shares rose 30.63% to $0.64.
The significant increase in Moleculin Biotech's share price is likely to have a positive impact on its stock in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Nkarta's shares moved upwards by 122.3% to $3.29 during Tuesday's regular session.
The significant increase in Nkarta's share price is likely to have a positive impact on its stock in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Olink Holding's stock moved upwards by 66.52% to $24.95.
The significant increase in Olink Holding's share price is likely to have a positive impact on its stock in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
OpGen's stock rose 24.19% to $1.13.
The significant increase in OpGen's share price is likely to have a positive impact on its stock in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Better Therapeutics' stock fell 12.99% to $0.25.
The significant decrease in Better Therapeutics' share price is likely to have a negative impact on its stock in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Celcuity's stock fell 14.58% to $8.97.
The significant decrease in Celcuity's share price is likely to have a negative impact on its stock in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Evelo Biosciences' shares declined by 57.0% to $1.25 during Tuesday's regular session.
The significant decrease in Evelo Biosciences' share price is likely to have a negative impact on its stock in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Monte Rosa Therapeutics' shares decreased by 16.0% to $4.2.
The significant decrease in Monte Rosa Therapeutics' share price is likely to have a negative impact on its stock in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Nuvectis Pharma's stock declined by 11.42% to $9.51.
The significant decrease in Nuvectis Pharma's share price is likely to have a negative impact on its stock in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Tiziana Life Sciences' shares fell 14.15% to $0.73.
The significant decrease in Tiziana Life Sciences' share price is likely to have a negative impact on its stock in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100